Association of non-insulin-based insulin resistance indices with disease severity and adverse outcome in idiopathic pulmonary arterial hypertension: a multi-center cohort study

[1]  Xueyuan Yang,et al.  Association of the triglyceride glucose-body mass index with the extent of coronary artery disease in patients with acute coronary syndromes , 2024, Cardiovascular diabetology.

[2]  Zhengwen Xu,et al.  Relationship between TyG index and the degree of coronary artery lesions in patients with H-type hypertension , 2024, Cardiovascular diabetology.

[3]  T. M. Zanotto,et al.  Pulmonary hypertension and insulin resistance: a mechanistic overview , 2024, Frontiers in endocrinology.

[4]  Gai-zhuo Liu.  Association between the metabolic score for insulin resistance (METS-IR) and arterial stiffness among health check-up population in Japan: a retrospective cross-sectional study , 2024, Frontiers in endocrinology.

[5]  Xiang-hui Zhang,et al.  Impact of the baseline insulin resistance surrogates and their longitudinal trajectories on cardiovascular disease (coronary heart disease and stroke): a prospective cohort study in rural China , 2023, Frontiers in endocrinology.

[6]  Jia-hao Dou,et al.  Association between triglyceride glucose-body mass and one-year all-cause mortality of patients with heart failure: a retrospective study utilizing the MIMIC-IV database , 2023, Cardiovascular Diabetology.

[7]  Kuo Zhang,et al.  High triglyceride-glucose (TyG) index is associated with poor prognosis of heart failure with preserved ejection fraction , 2023, Cardiovascular Diabetology.

[8]  Robert Ryczek,et al.  Impact of diabetes mellitus on disease severity and patient survival in idiopathic pulmonary arterial hypertension: data from the Polish multicentre registry (BNP-PL) , 2023, Cardiovascular Diabetology.

[9]  Zenglei Zhang,et al.  Association between non-insulin-based insulin resistance indices and cardiovascular events in patients undergoing percutaneous coronary intervention: a retrospective study , 2023, Cardiovascular Diabetology.

[10]  Xuefeng Yu,et al.  Predictive values of metabolic score for insulin resistance on risk of major adverse cardiovascular events and comparison with other insulin resistance indices among Chinese with and without diabetes mellitus: Results from the 4C cohort study , 2023, Journal of diabetes investigation.

[11]  Eric L. Johnson,et al.  2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. , 2022, Diabetes care.

[12]  Naifeng Liu,et al.  Relationship between a novel non–insulin-based metabolic score for insulin resistance (METS‐IR) and coronary artery calcification , 2022, BMC Endocrine Disorders.

[13]  S. Rosenkranz,et al.  Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis. , 2022, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  Xiang Wang,et al.  Association between the triglyceride–glucose index and severity of coronary artery disease , 2022, Cardiovascular Diabetology.

[15]  M. Humbert,et al.  2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. , 2022, European heart journal.

[16]  F. Potus,et al.  Macrophage–NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension , 2022, American journal of respiratory and critical care medicine.

[17]  Robert A. Lewis,et al.  Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis , 2022, The Lancet. Respiratory medicine.

[18]  Xin Zhang,et al.  Correlation between non‐insulin‐based insulin resistance indexes and the risk of prehypertension: A cross‐sectional study , 2022, Journal of clinical hypertension.

[19]  M. Toshner,et al.  Prevalence and clinical significance of conduction disease in patients with idiopathic pulmonary arterial hypertension. , 2022, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  Sung‐A Chang,et al.  A Retrospective Population-Based Survival Study of Idiopathic Pulmonary Arterial Hypertension in Korea , 2022, Journal of Korean medical science.

[21]  G. Z. Rocha,et al.  Pulmonary Hypertension in Obese Mice Is Accompanied by a Reduction in PPAR-γ Expression in Pulmonary Artery , 2021, Frontiers in Endocrinology.

[22]  G. Shulman,et al.  Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice , 2020, Proceedings of the National Academy of Sciences of the United States of America.

[23]  W. Seeger,et al.  Evaluation of pulmonary hypertension by right heart catheterisation: does timing matter? , 2020, European Respiratory Journal.

[24]  X. Liu,et al.  Association of Three Simple Insulin Resistance Indexes with Prehypertension in Normoglycemic Subjects. , 2019, Metabolic syndrome and related disorders.

[25]  P. Podolec,et al.  Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio and Systemic Inflammation in Patients with Idiopathic Pulmonary Arterial Hypertension , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[26]  Y. Shyr,et al.  Human PAH is characterized by a pattern of lipid-related insulin resistance. , 2019, JCI insight.

[27]  J. Stokwiszewski,et al.  Prognostic role of traditional cardiovascular risk factors in patients with idiopathic pulmonary arterial hypertension , 2018, Archives of medical science : AMS.

[28]  M. Humbert,et al.  Association Between BMI and Obesity With Survival in Pulmonary Arterial Hypertension , 2018, Chest.

[29]  Thomas Kahan,et al.  2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.

[30]  E. Bedrick,et al.  Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial Hypertension. , 2018, The American journal of medicine.

[31]  D. Zozulinska-Ziolkiewicz,et al.  TG/HDL-C ratio and visceral adiposity index may be useful in assessment of insulin resistance in adults with type 1 diabetes in clinical practice. , 2018, Journal of clinical lipidology.

[32]  Omar Yaxmehen Bello-Chavolla,et al.  METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. , 2018, European journal of endocrinology.

[33]  M. Pencina,et al.  Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension , 2017, Scientific Reports.

[34]  R. Dweik,et al.  Abnormal Glucose Metabolism and High‐Energy Expenditure in Idiopathic Pulmonary Arterial Hypertension , 2017, Annals of the American Thoracic Society.

[35]  E. Abel,et al.  Insulin Signaling and Heart Failure. , 2016, Circulation research.

[36]  L. Hsu,et al.  Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals , 2016, PloS one.

[37]  J. Sowers,et al.  Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy , 2016, Nature Reviews Endocrinology.

[38]  Stephen Kaptoge,et al.  BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis , 2016, The Lancet. Respiratory medicine.

[39]  Simon Gibbs,et al.  2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. , 2016, Revista espanola de cardiologia.

[40]  Stephan Rosenkranz,et al.  Right heart catheterisation: best practice and pitfalls in pulmonary hypertension , 2015, European Respiratory Review.

[41]  C. Molinari,et al.  Association between triglyceride to HDL‐C ratio and insulin resistance in indigenous Argentinean children , 2015, Pediatric diabetes.

[42]  Simon Gibbs,et al.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension , 2015, European Respiratory Journal.

[43]  R. Naeije,et al.  Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. , 2014, American journal of respiratory and critical care medicine.

[44]  A. Hsi,et al.  Impact of insulin resistance on ventricular function in pulmonary arterial hypertension. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[45]  M. Laakso,et al.  Insulin resistance and hyperglycaemia in cardiovascular disease development , 2014, Nature Reviews Endocrinology.

[46]  M. Mcgoon,et al.  Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis. , 2013, Chest.

[47]  C. Mineo,et al.  Novel biological functions of high-density lipoprotein cholesterol. , 2012, Circulation research.

[48]  W. Seeger,et al.  HbA1c in pulmonary arterial hypertension: a marker of prognostic relevance? , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[49]  L. Gleaves,et al.  A potential role for insulin resistance in experimental pulmonary hypertension , 2012, European Respiratory Journal.

[50]  R. Dweik,et al.  Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension. , 2010, American journal of respiratory and critical care medicine.

[51]  R. Trembath,et al.  Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension , 2010, Circulation.

[52]  M. Rodríguez-Moran,et al.  The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. , 2010, The Journal of clinical endocrinology and metabolism.

[53]  Z. Jing,et al.  Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension. , 2007, Chest.

[54]  T. W. Haeften,et al.  Determinants of insulin sensitivity in chronic heart failure , 2003, European journal of heart failure.

[55]  D. Le Roith,et al.  Recent advances in our understanding of insulin action and insulin resistance. , 2001, Diabetes care.

[56]  G. Meneilly,et al.  Assessment of Insulin Sensitivity in Older Adults Using the Hyperglycemic Clamp Technique , 1998, Journal of the American Geriatrics Society.

[57]  S. Anker,et al.  Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. , 1997, Journal of the American College of Cardiology.

[58]  N. Dhalla,et al.  Role of microangiopathy in diabetic cardiomyopathy , 2013, Heart Failure Reviews.

[59]  B. Zafrir,et al.  The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the "obesity paradox". , 2013, Respiratory medicine.

[60]  M. Rabinovitch.  PPARgamma and the pathobiology of pulmonary arterial hypertension. , 2010, Advances in experimental medicine and biology.

[61]  S. Aizawa,et al.  PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. , 1999, Molecular cell.

[62]  S. Rich,et al.  Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary hypertension. , 1985, The American journal of cardiology.